| Literature DB >> 21264117 |
Abstract
H(2)S has been proposed as physiological important molecule. It is considered as first endogenous gaseous K(+) channel opener. K(+) ATP channel activity is mainly responsible for insulin secretion. K(+)ATP channel opening of β cells leads to inhibition of insulin secretion and channels closing leads to secretion. H2S is the gaseous K(+) ATP channel opener but it does not have channel specificity. So, H(2)S may have some effect on insulin secretion. H(2)S is high in Zuker diabetic fatty rats. That means H(2)S is high in insulin resistance condition. We tried to find out the role of H(2)S in insulin secretion and in development of insulin resistance. From the result of our study, H(2)S have K(+) ATP channel opening activity on β cells. H(2)S does not have any role in the development of insulin resistance. Decrease in insulin level in Zuker diabetic rat and streptozotocin-induced diabetic rat is due to high H(2)S level.Entities:
Keywords: Glucose; K+ ATP channel; hydrogen sulfide; insulin
Year: 2010 PMID: 21264117 PMCID: PMC3021689 DOI: 10.4103/0975-1483.63156
Source DB: PubMed Journal: J Young Pharm ISSN: 0975-1483
Effect of H2S on glucose and insulin level
| Time (min) | Glucose (mg %) | Insullin(μU/ml) | ||
|---|---|---|---|---|
| Saline treated | H2S treated | Saline treated | H2S treated | |
| 0 | 79.9±2.7 | 80.1±6.1 | 40 ±1.9 | 41.3 ±1.73 |
| 30 | 85.9±3.6 | 112.3±7.1 | 40.7 ±1.7 | 34.7±1.5 |
| 60 | 89.1±5.2 | 142.7±8.3 | 43.7±0.9 | 30.5 ±1.01 |
| 120 | 89.6±4.1 | 174.7±7.3 | 43.2±2.4 | 32.7±2.9 |
| 180 | 88.7±4 | 164.2±8.5 | 39.8 ±2 | 33.8 ±2.29 |
| 240 | 84.4±6.3 | 132.8±7.9 | 41.3±1.2 | 35 ±1.75 |
| 300 | 83.8±5.1 | 116.6±6.9 | 41 ±1.5 | 36.3±1.3 |
Each value is mean±SEM
P<0.05
Effect of glibenclamide on H2S-induced changes on glucose and insulin level
| Time (min) | Glucose (mg %) | Insullin(μU/ml) | ||
|---|---|---|---|---|
| Saline treated group | H2S + glibenclamide-treated group | Saline treated group | H2S + glibenclamide-treated group | |
| 0 | 81.6±2.6 | 79.5±2.7 | 38 ±1.9 | 40 ±0.9 |
| 30 | 83.5±2.9 | 84.7±3.6 | 41.6 ±0.7 | 42.3 ±1.2 |
| 60 | 86.3±4.1 | 86.6±5.2 | 43±1.2 | 41.9±1.3 |
| 120 | 84.2±3.5 | 85.4±4.1 | 42.2±1.4 | 44.1±1.6 |
| 180 | 88.7±3.2 | 85.7±4 | 40 ±2 | 42 ± 1.5 |
| 240 | 85.6±4 | 83.2±6.3 | 40.7±0.8 | 42.7±1.2 |
| 300 | 87.5±3.9 | 83.8±5.1 | 40 ±1.5 | 42±0.8 |
Each value is mean±SEM, *P<0.05
Figure 1Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05
Figure 2Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05
insulin and glucose level before and after 30 days treatment of H2S
| Glucose level (mg %) | Insullin(μU/ml) | |
|---|---|---|
| Before 30 days treatment of H2S | 82.4±1.83 | 42.12±0.54 |
| After 30 days treatment of H2S | 82.8±1.12 | 41.7±0.36 |
Each value is mean±SEM, *P<0.05